Order Article Reprints

Karu N, Kindt A, Lamont L, van Gammeren AJ, Ermens AAM, Harms AC, Portengen L, Vermeulen RCH, Dik WA, Langerak AW, et al. Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers. Metabolites. 2022; 12(7):619. https://doi.org/10.3390/metabo12070619

Karu, Naama, Alida Kindt, Lieke Lamont, Adriaan J. van Gammeren, Anton A. M. Ermens, Amy C. Harms, Lutzen Portengen, Roel C. H. Vermeulen, Willem A. Dik, Anton W. Langerak, and et al. 2022. "Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers" Metabolites 12, no. 7: 619. https://doi.org/10.3390/metabo12070619

Karu, N., Kindt, A., Lamont, L., van Gammeren, A. J., Ermens, A. A. M., Harms, A. C., Portengen, L., Vermeulen, R. C. H., Dik, W. A., Langerak, A. W., van der Velden, V. H. J., & Hankemeier, T. (2022). Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers. Metabolites, 12(7), 619. https://doi.org/10.3390/metabo12070619